Recent Finacing
Recent Raise
Agilis Biotherapeutics is a New York–based synthetic biology company developing DNA-based therapeutics for rare genetic diseases, collaborating with Intrexon to develop and commercialize treatments for Friedreich’s ataxia.
Focus Areas
Total Raised
Funding round